Pneumolysin: a multifunctional pneumococcal virulence factor
- PMID: 9452123
- DOI: 10.1016/s0022-2143(98)90073-7
Pneumolysin: a multifunctional pneumococcal virulence factor
Abstract
Pneumolysin (PLY) is a multifunctional pneumococcal virulence factor that appears to augment intrapulmonary growth and dissemination during the early pathogenesis of Streptococcus pneumoniae infection. Through its cytotoxicity to respiratory epithelium and endothelium, PLY disrupts pulmonary tissue barriers that serve as mechanical pulmonary defenses, thus facilitating S. pneumoniae growth and dissemination. Through direct inhibitory effects on immune and inflammatory cells and by activating complement, PLY inhibits bacterial clearance from the pulmonary interstitium and the blood. Because PLY stimulates local and systemic immune responses and enhances the immunogenicity of S. pneumoniae polysaccharide (PS), PLY-PS conjugates may form the basis for vaccines that not only induce protective and durable immune responses to pneumococcal PS but also generate neutralizing anti-PLY antibodies that can protect the respiratory mucosa from toxin-induced injury.
Similar articles
-
Dual function of pneumolysin in the early pathogenesis of murine pneumococcal pneumonia.J Clin Invest. 1995 Jan;95(1):142-50. doi: 10.1172/JCI117631. J Clin Invest. 1995. PMID: 7814608 Free PMC article.
-
Neutralizing antibodies elicited by a novel detoxified pneumolysin derivative, PlyD1, provide protection against both pneumococcal infection and lung injury.Infect Immun. 2012 Jun;80(6):2212-20. doi: 10.1128/IAI.06348-11. Epub 2012 Apr 2. Infect Immun. 2012. PMID: 22473606 Free PMC article.
-
The biology of pneumolysin.Subcell Biochem. 2014;80:145-60. doi: 10.1007/978-94-017-8881-6_8. Subcell Biochem. 2014. PMID: 24798011 Review.
-
Acacetin inhibits Streptococcus pneumoniae virulence by targeting pneumolysin.J Pharm Pharmacol. 2020 Aug;72(8):1092-1100. doi: 10.1111/jphp.13279. Epub 2020 May 10. J Pharm Pharmacol. 2020. PMID: 32390150
-
Virulence, immunity, and vaccine related to Streptococcus pneumoniae.Crit Rev Microbiol. 1991;18(2):89-114. doi: 10.3109/10408419109113510. Crit Rev Microbiol. 1991. PMID: 1930677 Review.
Cited by
-
Pneumolysin localizes to the cell wall of Streptococcus pneumoniae.J Bacteriol. 2009 Apr;191(7):2163-8. doi: 10.1128/JB.01489-08. Epub 2009 Jan 23. J Bacteriol. 2009. PMID: 19168620 Free PMC article.
-
Immunization with pneumolysin protects against both retinal and global damage caused by Streptococcus pneumoniae endophthalmitis.J Ocul Pharmacol Ther. 2010 Dec;26(6):571-7. doi: 10.1089/jop.2010.0077. Epub 2010 Oct 29. J Ocul Pharmacol Ther. 2010. PMID: 21034245 Free PMC article.
-
Human alpha-defensins inhibit hemolysis mediated by cholesterol-dependent cytolysins.Infect Immun. 2009 Sep;77(9):4028-40. doi: 10.1128/IAI.00232-09. Epub 2009 Jul 6. Infect Immun. 2009. PMID: 19581399 Free PMC article.
-
Phenotypic, genomic, and transcriptional characterization of Streptococcus pneumoniae interacting with human pharyngeal cells.BMC Genomics. 2013 Jun 9;14:383. doi: 10.1186/1471-2164-14-383. BMC Genomics. 2013. PMID: 23758733 Free PMC article.
-
Cholesterol as treatment for pneumococcal keratitis: cholesterol-specific inhibition of pneumolysin in the cornea.Invest Ophthalmol Vis Sci. 2007 Jun;48(6):2661-6. doi: 10.1167/iovs.07-0017. Invest Ophthalmol Vis Sci. 2007. PMID: 17525197 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources